SFRP2 and neoplasm: Loss of SFRP2 expression is also found in oral squamous cell carcinoma, and SFRP2 overexpression inhibits proliferation, cell cycle progression, and tumor growth by increasing the expression of GSK-3β and β-catenin [28].